|
Volumn 16, Issue 9, 2010, Pages 1457-
|
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
DELTA OPIATE RECEPTOR;
KAPPA OPIATE RECEPTOR;
MU OPIATE RECEPTOR;
NALTREXONE;
PREDNISONE;
TUMOR NECROSIS FACTOR ALPHA;
ADOLESCENT;
ANTIINFLAMMATORY ACTIVITY;
CAPSULE ENDOSCOPY;
CASE REPORT;
CHILDHOOD DISEASE;
CROHN DISEASE;
DISEASE ACTIVITY;
DISEASE DURATION;
DRUG BINDING SITE;
DUODENITIS;
DUODENUM BIOPSY;
DUODENUM DISEASE;
ESOPHAGOGASTRODUODENOSCOPY;
FEMALE;
HELICOBACTER INFECTION;
HUMAN;
IMMUNOREGULATION;
JEJUNUM;
LETTER;
LOW DRUG DOSE;
MUSCLE RIGIDITY;
MYALGIA;
PRIORITY JOURNAL;
SEROLOGY;
UPPER ABDOMINAL PAIN;
WHEELCHAIR;
ADOLESCENT;
CROHN DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DUODENAL DISEASES;
FEMALE;
HUMANS;
NALTREXONE;
NARCOTIC ANTAGONISTS;
TREATMENT OUTCOME;
|
EID: 77956273358
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1002/ibd.21185 Document Type: Letter |
Times cited : (7)
|
References (4)
|